True Vision MN’s Merck MRK Stock Holding History

True Vision MN’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,158	Closed	-$475K	–	112
2024 Q3	$475K	Buy	4,158 +655	+19%	+$77.8K	0.28%	66
2024 Q2	$436K	Buy	+3,503	New	+$451K	0.28%	70

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

True Vision MN's MRK Position: Q4 2024 in Review

True Vision MN sold out of Merck (MRK) in Q4 2024, closing a stake of 4,158 shares — an estimated $475K sold.

True Vision MN first reported a position in MRK in Q2 2024 and held it in 2 quarters. The position peaked at $475K in Q3 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

True Vision MN reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
True Vision MN sold 4,158 Merck shares in Q4 2024, an estimated $475K.
True Vision MN first reported a position in Merck in Q2 2024 and held it in 2 quarters.
True Vision MN's Merck position peaked at $475K in Q3 2024.
3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on True Vision MN's 13F filing for Q4 2024, filed 29 Jan 2025.